InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-20.1%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Alexandria Venture Investments, LLC. Director active across 3 companies, notably Singular Genomics Systems, Inc.. In total, 6 reports have been recorded. Activity tracked since 1 June 2021. The latest transaction was disclosed on 1 June 2021 (C). Regulator: SEC (Form 4). All data is free.
Declarations6 total
192,973 sharesCommon stockSEC:0001722024-22-000004:0
192,973 sharesCommon stockSEC:0001722024-22-000004
166,423 sharesCommon stockSEC:0001722024-21-000012:0
166,423 sharesCommon stockSEC:0001722024-21-000012
2,645,985 shares0Common stockSEC:0001722024-21-000008
2,645,985 shares0Common stockSEC:0001722024-21-000008:0
6 of 6 declarations
About Alexandria Venture Investments, LLC
Alexandria Venture Investments, LLC is a director and insider for several companies, including Singular Genomics Systems, Inc., Xilio Therapeutics, Inc., and Vigil Neuroscience, Inc.
